FDA Investigator Vilmary Negron Rodriguez

Vilmary Negron Rodriguez has conducted inspections on 62 sites in 15 countries as of 16 Mar 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
62
Last Inspection Date:
16 Mar 2021
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Mexico, Spain, Puerto Rico, Israel, Japan, Hungary, India, China, United States of America, France, Germany, Poland, Switzerland, United Kingdom of Great Britain and Northern Ireland, Croatia
FDA Investigators that have inspected at least one site in common with Vilmary Negron Rodriguez:
Abby E Pelletier, Adaliz Santaliz Cruz, Adetutu M Gidado, Agnes M Santori, Alan A Rivera, Alicia M Mozzachio, Ana M Rivera, Ana P Pineda Zavaleta, Anastasia M Shields, Andrea George, PhD, Angela E Glenn, Angelica M Hernandez, Anita Narula, PhD, Ann L Demarco, Anna Lazar, Anne L Aberdeen, Annette Melendez, Anthony E Keller, RPh, Ariel Cruz Figueroa, Arlene M Badillo, Arsen Karapetyan, Arwa S El Hagrasy, Ashar P Parikh, Ashley N Queen, PhD, Azza Talaat, Barbara J Rincon, Barbara Janine Breithaupt, Binh T Nguyen, Bo Chi, PhD, Brenda Rivera, Brooke K Higgins, Calvin B Koerner, Carl A Huffman, III, Carla J Lundi, Carlos A Medina, Carpios, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charisse K Green, Charles R Cote, RIC, Cheryl A Clausen, Christina Capacci Daniel, PhD, Christopher D Rush, Christopher Downey, PhD, Christopher T Middendorf, Colleen Thomas, PhD, Cynthia J Lee, MS, Cynthia Jim, CSO, Daniel J Roberts, Daniel L Obrzut, Daniel W Cline, Darla J Christopher, David G Eng, Dayna I Martinez, Debra I Love, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Djamila Harouaka, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Dongping Dai, PhD, Donna Christner, Douglas A Campbell, Douglas C Kovacs, Dov H Pluznik, PhD, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Robert C Horan, MD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edwin Martinez, Eileen A Liu, Eliezar Ramos, Ellen C Weisensel, Enrique Galan, Erika E Englund, PhD, Erika V Butler, Eva I Merced Medina, Farhana Khan, Felix Maldonado, Frances L Dejesus, Francis A Guidry, Frederick F Razzaghi, Gam S Zamil, Gavin T Cua, German Rivera, Guerlain Ulysse, Helen B Ricalde, Iraida Ortiz, Ivis L Negron, Jacob G Lutz, Jaime E Pares, James L Dunnie, Jr, James Norman, Jeffery A Hangartner, Jeffrey A Sommers, Jennifer Lalama, Jerri Baker, Joan M Cantellops Figueroa, Jodi M Gatica, Jorge E Martinez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose Martinez, Jr, Jose R Hernandez, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, June P Page, Junho Pak, Justin A Boyd, Katherine Szestypalow, Katherine V Serrano, Kejun Cheng, Kellia N Hicks, Kenneth H Williams, Kevin P Foley, Kim Lthomas Cruse, Krishna Ghosh, PhD, Kumar G Janoria, L Grant, Laiza V Garcia, Lareese K Thomas, Laura E Garcia, Laurimer Kuilan Torres, Leslie A Mendoza, Liatte Kreuger, PharmD, Libia M Lugo, Linda F Murphy, Lisa M Lopez, Lizaida E Rodriguez, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, Lucila B Nwatu, Luella J Rossi, Luis A Dasta, Luis Mburgos Medero, Lynda L Perry, PhD, Margarita Santiago, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte Cruz, Maribel V Juarbe, Marie A Fadden, Marilyn Santiago, Mark C Saale, Mary E Farbman, PhD, Maryam Tabatabaie, Massoud Motamed, Matthew A Johnson, Matthew B Casale, Matthew R Maddox, Maxwell Van Tassell, PhD, Michael A Charles, Michael E Maselli, Michael L Casner, Michael R Klapal, Michael S Araneta, Michael Shanks, MS, Michelle Yclark Stuart, Miguel A Martinez Perez, Milva E Melendez Perales, Monica Cburgos Garcia, Moraima Jramos Valle, Mra M Barbosar, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nancy Rosado, Narong Chamkasem, PhD, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nicholas Obiri, PhD, Nikolay Spiridonov, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Paraluman S Leonin, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul A Bonneau, Paul Z Balcer, Paula A Trost, Prabhu P Raju, Rachael A Moliver, Rafael Nevarez Nieves, Ramesh Potla, PhD, Ramon A Hernandez, Randy L Self, Rapti D Madurawe, Raquel Gonzalez Rivera, Raymond T Oji, Reba A Gates, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Riley C Myers, PhD, Rita K Kabaso, Rita K Vick, Robert Darius, Robert J Doyle, Robert Jennings, Robert M Barbosa, Rodney G Raiford, Rozelle G Smith, Russell J Glapion, Saleem A Akhtar, Samina S Khan, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sanket N Patel, Santos E Camara, Sarah Ibrahim, Sarah M Meng, Satheesh Thomas, Scott B Laufenberg, Scott T Ballard, Seema S Singh, Sena G Dissmeyer, Sharmista Chatterjee, Sharon K Thoma, PharmD, Simone E Pitts, Sina Shojaee, Sonia M Monges, Sonia R Peterson, Sonya M Edmonds, Stephanie A Slater, MS, Stephen D Brown, Stephen J Mottola, Steven A Gonzales, Steven B Barber, Steven C Madzo, Steven Fong, MS, PhD, Steven P Donald, Susan T Hadman, Susanna E Ford, Taichun Qin, PhD, Tara L Greene, Teresa I Navas, Terri L Dodds, Thomas J Arista, Timothy T Kapsala, Timothy Wadkin, PhD, Tonia F Bernard, Torrance J Slayton, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Victor S Pacheco, Walden H Lee, Wanda J Torres, Wayne D Mcgrath, Wayne E Seifert, Wendy G Tan, PhD, Yasamin Ameri, Yifan Wang, Ying Zhang, Yumi J Hiramine, Zachary L Stamm, Zhong Li, PhD

Vilmary Negron Rodriguez's Documents

Publish Date Document Type Title
February, 2020 FDA 483 MSD International GmbH (Puerto Rico Branch) LLC - Form 483, 2020-02-26
March, 2018 FDA 483 Auro PR Inc. - Form 483, 2018-03-15
February, 2015 EIR Baxter Healthcare Corporation - EIR, 2015-02-06
May, 2015 FDA 483 Janssen Ortho LLC - Form 483, 2015-05-29
May, 2017 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2017-05-10
February, 2015 FDA 483 Baxter Healthcare Corporation - Form 483, 2015-02-06
April, 2018 EIR Astral SteriTech Private Limited - EIR, 2018-04-03
February, 2017 FDA 483 Omega & Delta Co. Inc. - Form 483, 2017-02-07
April, 2018 FDA 483 Zydus Hospira Oncology Private Limited - Form 483, 2018-04-12
February, 2020 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2020-02-26
November, 2015 EIR Galephar Pharmaceutical Research Inc - EIR, 2015-11-23
December, 2018 EIR Sun Pharmaceutical Industries Limited - EIR, 2018-12-06
April, 2019 FDA 483 Suzhou Homesun Pharmaceutical Co., Ltd. - Form 483, 2019-04-12
July, 2019 FDA 483 Mary Kay, Inc - Form 483, 2019-07-19
March, 2018 EIR Auro PR Inc. - EIR, 2018-03-15
February, 2016 FDA 483 MSN LABORATORIES PRIVATE LIMITED - Form 483, 2016-02-05
January, 2016 EIR TYCHE INDUSTRIES LIMITED - EIR, 2016-01-29
April, 2019 FDA 483 Hangzhou Facecare Cosmetics Co., Ltd. - Form 483, 2019-04-05
June, 2016 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2016-06-21
March, 2016 FDA 483 Professional Arts Pharmacy - Form 483, 2016-03-23
December, 2017 FDA 483 Nipro Pharma Corporation - Form 483, 2017-12-15
November, 2015 FDA 483 Galephar Pharmaceutical Research Inc - Form 483, 2015-11-23
October, 2016 FDA 483 Warner Chilcott Company, LLC - Form 483, 2016-10-03
August, 2015 FDA 483 American Specialty Pharmacy - Form 483, 2015-08-05
December, 2018 FDA 483 Intas Pharmaceuticals Limited - Form 483, 2018-12-14
August, 2018 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2018-08-06
December, 2015 FDA 483 NATIONAL VITAMIN COMPANY - Form 483, 2015-12-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more